Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Radiology|February 4, 2003
Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spreadGuy J C Burkill, Mohammed Badran, Omar Al-Muderis, et al.
World Journal of Surgical Oncology|June 20, 2008
Late widespread skeletal metastases from myxoid liposarcoma detected by MRI onlySammy A Hanna, Yassar A Qureshi, Lee Bayliss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopyYuen-Li Chung, Helen Troy, Ian R Judson, et al.
British Journal of Cancer|May 11, 2024
UK guidelines for the management of soft tissue sarcomasAndrew J Hayes, Ioanna F Nixon, Dirk C Strauss, et al.
Cancer Chemotherapy and Pharmacology|November 12, 2010
Clinical benefit of early phase clinical trial participation for advanced sarcoma patientsRobin L Jones, David Olmos, Khin Thway, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331Hugo E R Ford, Fraser Mitchell, David Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2005
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mgJohn R Zalcberg, Jaap Verweij, Paolo G Casali, et al.
Clinical Sarcoma Research|August 5, 2014
Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experienceAnna Maria Frezza, Charlotte Benson, Ian R Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2003
Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma GroupAllan T van Oosterom, Ian R Judson, Jaap Verweij, et al.
Pageof 5